# A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision

> **NCT06664151** · EARLY_PHASE1 · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 25 (estimated)

## Conditions studied

- Skin Cancer
- Cutaneous Squamous Cell Carcinoma (CSCC)
- Cutaneous Squamous Cell Cancer

## Interventions

- **BIOLOGICAL:** Fluzone Trivalent

## Key facts

- **NCT ID:** NCT06664151
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-26
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06664151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06664151, "A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT06664151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*